Pfizer
Trade Pfizer 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About PFE
Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases.
PFE Key Statistics
Stock Snapshot
With a market cap of 143.17B, Pfizer(PFE) trades at $25.19. The stock has a price-to-earnings ratio of 14.68 and currently yields dividends of 6.8%.
On 2026-01-04, Pfizer(PFE) stock moved within a range of $24.83 to $25.30. With shares now at $25.19, the stock is trading +1.4% above its intraday low and -0.4% below the session's peak.
Trading volume for Pfizer(PFE) stock has reached 35.98M, versus its average volume of 38.53M.
Over the past 52 weeks, Pfizer(PFE) stock has traded between a high of $27.69 and a low of $20.92.
Over the past 52 weeks, Pfizer(PFE) stock has traded between a high of $27.69 and a low of $20.92.
PFE News
Key Points Pfizer's dividend payout ratio is high, but the company is generated enough free cash flow to cover its dividend. Management remains committed to t...
Shares in Ironwood Pharmaceuticals (IRWD), which creates and sells medicines for people with severe stomach and digestive problems, ballooned over 30% on Friday...
It might not pay off immediately, but it could, eventually. Trading at a bit under $25 apiece, Pfizer's (PFE 0.28%) shares appear tentatively cheap. However, t...
Analyst ratings
56%
of 27 ratingsMore PFE News
Key Points Ares Capital offers an especially juicy dividend. Energy Transfer has an impressive track record of increasing its distribution each quarter. Pfiz...
Key Points Pfizer’s revenue soared to record heights a few years ago thanks to its coronavirus products, but growth has since slowed. The company is counting o...
American pharma giant Pfizer (PFE) leads the pack as pharmaceutical companies plan price increases for at least 350 branded medications, according to data seen...
Drugmakers are reportedly preparing to raise U.S. prices on at least 350 branded medicines in 2026, including vaccines for COVID-19, RSV, and shingles, as well...
Pfizer Inc (PFE) announced an update on their ongoing clinical study. Claim 70% Off TipRanks This Holiday Season Pfizer has completed a Phase 1 trial titled “...
Key Points Over the last half-century, dividend stocks have notably outperformed non-payers -- and have done so while being less volatile than the benchmark S&...
Option traders moderately bearish in Pfizer (PFE), with shares down 4c near $25.05. Options volume relatively light with 66k contracts traded and calls leading...